Emerald Mutual Fund Advisers Trust Grows Stock Holdings in Lumexa Imaging Holdings, Inc. $LMRI

Emerald Mutual Fund Advisers Trust boosted its holdings in Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) by 11.0% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 653,342 shares of the company’s stock after purchasing an additional 64,677 shares during the quarter. Emerald Mutual Fund Advisers Trust owned approximately 0.68% of Lumexa Imaging worth $5,619,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in LMRI. T. Rowe Price Investment Management Inc. acquired a new position in Lumexa Imaging in the fourth quarter valued at $37,139,000. Janus Henderson Group PLC acquired a new position in Lumexa Imaging during the 4th quarter worth $36,860,000. Healthcare of Ontario Pension Plan Trust Fund bought a new position in shares of Lumexa Imaging in the 4th quarter worth about $27,750,000. ArrowMark Colorado Holdings LLC acquired a new position in Lumexa Imaging during the 4th quarter valued at approximately $27,750,000. Finally, Invesco Ltd. acquired a new position in Lumexa Imaging during the 4th quarter valued at about $26,562,000.

Insider Buying and Selling at Lumexa Imaging

In other news, Director Brett Brodnax bought 35,000 shares of the firm’s stock in a transaction on Tuesday, May 19th. The shares were purchased at an average cost of $7.25 per share, with a total value of $253,750.00. Following the acquisition, the director directly owned 62,027 shares in the company, valued at $449,695.75. This represents a 129.50% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.70% of the company’s stock.

Lumexa Imaging Trading Down 7.1%

NASDAQ LMRI opened at $11.15 on Tuesday. The company has a debt-to-equity ratio of 1.43, a current ratio of 1.40 and a quick ratio of 1.40. The company has a market capitalization of $1.07 billion and a price-to-earnings ratio of -18.90. Lumexa Imaging Holdings, Inc. has a 1 year low of $6.45 and a 1 year high of $19.45. The stock’s fifty day moving average price is $9.48.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on LMRI shares. Wall Street Zen upgraded Lumexa Imaging from a “hold” rating to a “buy” rating in a report on Saturday, June 27th. Barclays reduced their price objective on Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating for the company in a research report on Wednesday, May 20th. Finally, Weiss Ratings raised shares of Lumexa Imaging from a “sell (e)” rating to a “sell (d)” rating in a report on Thursday, June 25th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, Lumexa Imaging presently has a consensus rating of “Moderate Buy” and a consensus price target of $16.00.

Lumexa Imaging Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).